KeyBank National Association’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
27,809
+13,265
+91% +$618K ﹤0.01% 533
2025
Q4
$705K Buy
14,544
+3,479
+31% +$172K ﹤0.01% 679
2025
Q3
$522K Sell
11,065
-2,300
-17% -$111K ﹤0.01% 777
2025
Q2
$646K Sell
13,365
-71
-0.5% -$3.63K ﹤0.01% 692
2025
Q1
$745K Buy
13,436
+3,331
+33% +$180K ﹤0.01% 624
2024
Q4
$487K Buy
10,105
+913
+10% +$46.4K ﹤0.01% 790
2024
Q3
$530K Sell
9,192
-10,605
-54% -$573K ﹤0.01% 750
2024
Q2
$961K Buy
19,797
+144
+0.7% +$6.95K ﹤0.01% 549
2024
Q1
$955K Sell
19,653
-1,854
-9% -$90.5K ﹤0.01% 547
2023
Q4
$1.07M Buy
21,507
+1,077
+5% +$52.7K ﹤0.01% 502
2023
Q3
$1.1M Sell
20,430
-82
-0.4% -$4.37K 0.01% 447
2023
Q2
$1.11M Buy
20,512
+133
+0.7% +$7.16K 0.01% 463
2023
Q1
$1.11M Buy
20,379
+2,948
+17% +$143K 0.01% 460
2022
Q4
$844K Buy
17,431
+633
+4% +$27.8K ﹤0.01% 504
2022
Q3
$639K Sell
16,798
-622
-4% -$27.7K ﹤0.01% 567
2022
Q2
$872K Sell
17,420
-2,121
-11% -$113K ﹤0.01% 492
2022
Q1
$1M Buy
19,541
+12,446
+175% +$643K ﹤0.01% 511
2021
Q4
$355K Buy
7,095
+634
+10% +$31.4K ﹤0.01% 885
2021
Q3
$311K Buy
6,461
+113
+2% +$5.75K ﹤0.01% 932
2021
Q2
$334K Buy
6,348
+67
+1% +$3.5K ﹤0.01% 918
2021
Q1
$311K Buy
6,281
+479
+8% +$23K ﹤0.01% 914
2020
Q4
$282K Sell
5,802
-1,777
-23% -$87.6K ﹤0.01% 914
2020
Q3
$380K Buy
7,579
+691
+10% +$35.6K ﹤0.01% 770
2020
Q2
$352K Sell
6,888
-217
-3% -$10.5K ﹤0.01% 771
2020
Q1
$311K Sell
7,105
-959
-12% -$45.9K ﹤0.01% 750
2019
Q4
$405K Buy
8,064
+1,631
+25% +$76.4K ﹤0.01% 784
2019
Q3
$298K Sell
6,433
-182
-3% -$7.85K ﹤0.01% 842
2019
Q2
$286K Buy
6,615
+217
+3% +$9.23K ﹤0.01% 878
2019
Q1
$283K Sell
6,398
-547
-8% -$23.4K ﹤0.01% 841
2018
Q4
$301K Buy
6,945
+463
+7% +$20.4K ﹤0.01% 794
2018
Q3
$290K Sell
6,482
-590
-8% -$25.2K ﹤0.01% 912
2018
Q2
$283K Sell
7,072
-700
-9% -$27.6K ﹤0.01% 895
2018
Q1
$312K Sell
7,772
-1,135
-13% -$47.2K ﹤0.01% 872
2017
Q4
$383K Buy
8,907
+711
+9% +$32.8K ﹤0.01% 823
2017
Q3
$408K Buy
8,196
+1,000
+14% +$48.4K ﹤0.01% 840
2017
Q2
$345K Sell
7,196
-15
-0.2% -$717 ﹤0.01% 915
2017
Q1
$326K Buy
7,211
+497
+7% +$21.1K ﹤0.01% 950
2016
Q4
$272K Buy
6,714
+539
+9% +$21.2K ﹤0.01% 989
2016
Q3
$236K Buy
+6,175
New +$248K ﹤0.01% 1051
2016
Q2
Sell
-6,763
Closed -$272K 1126
2016
Q1
$272K Sell
6,763
-2,145
-24% -$86.2K ﹤0.01% 956
2015
Q4
$380K Buy
8,908
+3,035
+52% +$140K ﹤0.01% 873
2015
Q3
$279K Buy
5,873
+1,634
+39% +$83.2K ﹤0.01% 967
2015
Q2
$210K Sell
4,239
-3,375
-44% -$171K ﹤0.01% 1123
2015
Q1
$376K Sell
7,614
-872
-10% -$41.7K ﹤0.01% 939
2014
Q4
$387K Buy
8,486
+133
+2% +$6.45K ﹤0.01% 945
2014
Q3
$471K Sell
8,353
-484
-5% -$26K ﹤0.01% 885
2014
Q2
$470K Sell
8,837
-130
-1% -$6.9K ﹤0.01% 926
2014
Q1
$469K Sell
8,967
-41,779
-82% -$2.11M ﹤0.01% 924
2013
Q4
$2.72M Buy
50,746
+484
+1% +$25K 0.02% 338
2013
Q3
$2.54M Sell
50,262
-1,945
-4% -$99K 0.02% 336
2013
Q2
$2.69M Buy
+52,207
New +$2.78M 0.01% 582

Other funds holding SNY

KeyBank National Association's SNY Position: Q1 2026 in Review

KeyBank National Association increased its Sanofi (SNY) stake by 91% in Q1 2026, buying an estimated $618K and bringing the position to 27,809 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #533.

KeyBank National Association first reported a position in SNY in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.72M in Q4 2013. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • KeyBank National Association held 27,809 shares of Sanofi worth $1.34M as of Q1 2026.
  • KeyBank National Association bought 13,265 Sanofi shares in Q1 2026, an estimated $618K.
  • Sanofi made up ﹤0.01% of KeyBank National Association's portfolio in Q1 2026, its #533 holding.
  • KeyBank National Association first reported a position in Sanofi in Q2 2013 and has held it in 51 quarters since.
  • KeyBank National Association's Sanofi position peaked at $2.72M in Q4 2013.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.